共 351 条
[31]
Tolédano D(2014)The clinical spectrum of Erdheim-Chester disease: an observational cohort study Blood. 124 483-53
[32]
Cohen Aubart F(2009)Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease J Pediatr Hematol Oncol 31 782-392
[33]
Emile J-F(2016)Erdheim-Chester disease in childhood: a challenging diagnosis and treatment Childs Nerv Syst 32 893-520
[34]
Carrat F(2018)Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report J Neurosurg Pediatr 23 48-3138
[35]
Charlotte F(2004)Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis Medicine (Baltimore) 83 371-1277
[36]
Benameur N(2016)Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review J Am Acad Dermatol 74 513-594
[37]
Donadieu J(2009)Cutaneous manifestations of Erdheim-Chester disease (ECD): clinical, pathological, and molecular features in a monocentric series of 40 patients Arthritis Rheum 60 3128-2782
[38]
Diamond EL(2006)18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease J Neurol 253 1267-85
[39]
Durham BH(2010)Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature Radiology. 255 586-1925
[40]
Ulaner GA(2011)Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings Blood. 117 2778-313